• Home
  • About Tegal
    • About Tegal Corporation
    • Management Team
    • Board of Directors
    • Contact Tegal
  • Medical Technology
    • Medical Technology Overview
    • NanoVibronix Website
  • sequel power
    • sequel power Overview
    • sequel power Management
    • sequel power website
  • Products
    • Cu/Low-k Technology
    • NanoLayer Deposition (NLD)
    • Deep Reactive Ion Etch (DRIE)
    • Legacy RIE and PVD
  • Investor Relations
    • Investor Relations Home
    • Market Watch
    • Reports
    • Governance
    • Recent Communications
  • News
    • Press Releases
      • Press Release Archives

Reports

Email Print

Tegal Form 10Q FY2012 Q3 (pdf)

IRS Form 8937 - Report of Organizational Actions Affecting Basis of Securities

Tegal Form 10Q FY2012 Q2 (pdf)

Tegal Form 10-Q FY2012 Q1 (pdf)
XBRL: tgal-20110630.xsd | tgal-20110630.xml | tgal-20110630_pre.xml | tgal-20110630_lab.xml
| tgal-20110630_cal.xml

Tegal Form 10-K/A

Tegal 2011 Annual Report

Tegal 2010 Annual Report

Tegal 2010 Annual Meeting Notice & Proxy Statement

Tegal 2009 Annual Report

Tegal 2009 Annual Meeting Notice & Proxy Statement

Tegal 2008 Annual Report

Tegal 2008 Annual Meeting Notice & Proxy Statement

Tegal 2007 Annual Report

Tegal 2007 Annual Meeting Notice & Proxy Statement

Tegal 2006 Annual Report

Tegal 2005 Annual Report

Tegal 2005 Annual Meeting Notice & Proxy Statement

Tegal 2004 Annual Report

Tegal 2003 Annual Report

Tegal 2002 Annual Report

  • Investor Relations Home
  • Market Watch
  • Reports
  • Governance
  • Recent Communications
Facebook Twitter Linkedin
CSS Valid | XHTML Valid | Top

Copyright © Tegal Corporation 2012 All rights reserved.